American Well Corp is set to release its Q1 2026 earnings on 5 May 2026. Analysts expect revenue of $51.49 million and a loss of $1.15 per share for the quarter. Revenue estimates for the full year 2026 have declined from $240.41 million to $199.37 million over the past 90 days, whilst earnings estimates improved from a loss of $4.84 per share to $4.37 per share during the same period. In the previous quarter ending 31 December 2025, American Well beat revenue expectations by 4.95% and earnings estimates by 13.14%, resulting in a 24.71% share price increase. Analysts' average one-year price target of $6.50 suggests 6.21% upside from the current price of $6.12, with a consensus "Hold" rating from nine brokerage firms.

BOSTON--(BUSINESS WIRE)--Amwell®, (NYSE: AMWL) a leader in digital healthcare enablement, today announced that members of the Amwell management team will participate in the following upcoming investor conferences:. On November 10, 2022, Dr. Ido Schoenberg, Chairman and CEO, and Bob Shepardson, CFO, will attend the Credit Suisse 31 st Annual Healthcare Conference in Palos Verdes, CA, and will participate in an in-person fireside chat at 8:30 a.m. PT. They will also conduct one-on-one meetings with investors that day

BOSTON--(BUSINESS WIRE)--Amwell® (NYSE: AMWL), a digital care delivery leader, today announced the appointments of Vaughn Paunovich to the role of Executive Vice President, Enterprise Platforms, and Matthew McAllister to Chief Product Officer. Vaughn will oversee technological delivery and innovation, including for Converge™, Amwell’s enterprise grade digital care delivery platform, and Matthew will join Vaughn’s leadership team with responsibility for product management and design. “We are experiencing a time of great transformation for Amwell and for our industry. Customers today no longer want to buy features. They want a partner who can assimilate deep knowledge, experience, and interoperable technology to solve for their current and future digital aspirations,” said Roy Schoenberg, CEO, Amwell. “As we complete some of the most strategic aspects of the build-out of Converge, our digital care delivery platform, we are excited to have Vaughn and Matthew join our executive team. Both bring unparalleled experience leading digital transformation initiatives for some of the world’s leading health and technology companies and will contribute meaningfully to our rapid innovation, working in partnership with our customers to deliver the best-in-class, future-ready experiences they desire.”